Erasme Scientific Publications

Erasme Scientific Publications

  • Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus.

  • Auteurs Meletti S, Hanin A, Giovannini G, Bedin R, Burani M, Taruffi L, Orlandi N, Urbano T, D'Achille F, Malerba M, Basha MM, Eschbach K, Foreman B, Farias-Moeller R, Gaspard N, Gerard EE, Gofton T, Gopaul MT, Haider HA, Hantus ST, Herman S, Kang P, Day GS, Kandula P, Steriade C, Struck AF, Taraschenko O, Wainwright M, Yoo JY, Zhou DJ, Lattanzi S, Navarro V, Hirsch LJ
  • Revue JAMA Neurol
  • Date de publication 2026-04
Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus.

  • Non-invasive intracranial pressure estimation in the intensive care unit: narrative review of methods and clinical applications.

  • Auteurs Picetti E, Biasucci DG, Gouvea Bogossian E, Brasil S, Cardim D, Czosnyka M, Godoy DA, Hawryluk GWJ, Hirzallah MI, Rasulo FA, Bittencourt Rynkowski C, Rubiano AM, Taccone FS, Robba C
  • Revue Intensive Care Med
  • Date de publication 2026-04
Non-invasive intracranial pressure estimation in the intensive care unit: narrative review of methods and clinical applications.

  • Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.

  • Auteurs Fischler R, Lecoq AL, Houillier P, Verdoux M, Vantyghem MC, Briot K, Besson FL, Pierquet-Ghazzar N, Beron A, Viengchareun S, Trabado S, Lecoeuvre A, Bordet C, Goujard C, Salenave S, Leboulleux S, Carreira E, Chabrolle C, Corvilain B, Chanson P, Young J, Linglart A, Grimon G, Kamenický P
  • Revue Eur J Endocrinol
  • Date de publication 2026-04
Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.

  • A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer).

  • Auteurs Yau T, Galle PR, Decaens T, Sangro B, Qin S, da Fonseca LG, Karachiwala H, Blanc JF, Park JW, Gane E, Pinter M, Matilla Peña A, Ikeda M, Tai D, Santoro A, Pizarro G, Chiu CF, Schenker M, He A, Chon HJ, Wojcik-Tomaszewska J, Verset G, Wang QQ, Stromko C, Neely J, Singh P, Jimenez Exposito MJ, Kudo M
  • Revue Future Oncol
  • Date de publication 2026-04
A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer).

  • Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome.

  • Auteurs Betrains A, Jachiet V, Dieudonné Y, Dion J, Lazaro E, Jean A, de Moreuil C, Ardois S, Grosleron S, Arlet JB, Durel CA, Delaval L, Papo T, Herbin Cavaro AC, Vinzio S, Martis N, Bouillet L, Audia S, Nicolas B, Golden C, Langlois V, Perlat A, Vandergheynst F, Decker P, Moulinet T, Lacombe V, Samson M, Blockmans D, Kosmider O, Georgin-Lavialle S, Mekinian A, Terrier B
  • Revue Rheumatology (Oxford)
  • Date de publication 2026-04
Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome.
Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet
Decorative image of doctor and patient

All scientific publications by the H.U.B.

View all scientific publications from the H.U.B.

All scientific publications